Chemistry of Medicinal Plants Department, National Research Centre, 33 El-Bohouth St., Dokki, Giza, 12622, Egypt.
Chemistry Department, Biochemistry Division, Faculty of Science, Mansoura University, Mansoura, 35516, Egypt.
BMC Complement Med Ther. 2024 Aug 1;24(1):294. doi: 10.1186/s12906-024-04484-4.
cultivated and wild plants are used to treat different ailments. The Astragalus genus is found in temperate and dry climates; thus, it is found in Egypt and the arab world. Astragalus caprinus has a good amount of bioactive chemicals, which may help explain its therapeutic effects in reducing the risk of consequences from disease.
The phytochemical investigation of the herb and roots of Astragalus caprinus L. included the analytical characterization for the petroleum ether components by GC/MS, unsaponifiable matter (unsap. fraction), and fatty acids (FAME) investigation by GLC analysis. Main flavonoids were chromatographically isolated from ethyl acetate and n-butanol extracts. In vitro antimicrobial activity has been tested against the Gram-positive bacteria Staphylococcus aureus and Streptococcus mutans for different plant extracts, the Gram-negative bacteria Pseudomonas aeruginosa and Klebsiella pneumonia, the fungus Candida albicans and Aspergillus niger, and the Escherichia coli bacterium. Metabolite cytotoxicity was examined using the MTT assay against HepG-2 (human liver carcinoma) and MCF-7 (breast carcinoma).
Identifying the important components of the herb and root petroleum ether extracts was achieved. Using column chromatography, luteolin, cosmosiin (apigenin-7-O-glucoside), and cynaroside (luteolin-7-O-glucoside) were separated and identified using UV, NMR, and Mass Spectroscopy. Root extracts displayed potential antimicrobial activity against most of the tested pathogens. Both extracts (herb and roots) were active against the MCF-7 cell line and HepG-2 cell line with IC 62.5 ± 0.64 and 72.4 ± 2.3 µg/ml, and 75.9 ± 2.5 and 96.8 ± 4.2 µg/ml, respectively.
Astragalus caprinus seems to be a promising source of bioactive compounds that could potentially aid in preventing disease complications and address common health issues in developing countries. Moreover, the various parts of this plant could be utilized as natural raw materials for producing health-boosting products that could address common health issues in developing countries.
栽培植物和野生植物被用于治疗不同的疾病。黄芪属植物分布于温带和干旱气候地区;因此,它分布于埃及和阿拉伯世界。黄芪 caprinus 含有大量的生物活性化学物质,这可能有助于解释其在降低疾病后果风险方面的治疗效果。
对黄芪 caprinus L. 的草药和根的植物化学研究包括通过 GC/MS 对石油醚成分进行分析表征、不皂化物(unsap. 馏分)和脂肪酸(FAME)的 GLC 分析。主要类黄酮从乙酸乙酯和正丁醇提取物中进行色谱分离。对不同植物提取物的革兰氏阳性菌金黄色葡萄球菌和变异链球菌、革兰氏阴性菌铜绿假单胞菌和肺炎克雷伯菌、真菌白色念珠菌和黑曲霉以及大肠杆菌进行了体外抗菌活性测试。使用 MTT 测定法对 HepG-2(人肝癌)和 MCF-7(乳腺癌)细胞进行了代谢物细胞毒性测试。
鉴定了草药和根石油醚提取物的重要成分。使用柱色谱法,分离并鉴定了芹菜素、芹菜素-7-O-葡萄糖苷( cosmosiin )和毛蕊花糖苷( luteolin-7-O-glucoside ),使用 UV、NMR 和质谱法。根提取物对大多数测试病原体表现出潜在的抗菌活性。草药和根提取物均对 MCF-7 细胞系和 HepG-2 细胞系具有活性,IC 62.5 ± 0.64 和 72.4 ± 2.3 µg/ml,75.9 ± 2.5 和 96.8 ± 4.2 µg/ml。
黄芪 caprinus 似乎是生物活性化合物的有前途的来源,可能有助于预防疾病并发症,并解决发展中国家的常见健康问题。此外,这种植物的各个部分可以用作生产有助于健康的产品的天然原料,以解决发展中国家的常见健康问题。